sBioMed develops anthrax sporicide

sBioMed, a Utah-based biomedical research firm, has developed an Environmental Protection Agency approved sporicide that can be used in the remediation of buildings that have been contaminated with anthrax.
STERIPLEX Ultra is a non-corrosive, non-fuming, non-toxic substance that kills anthrax spores in 30 minutes and may allow contaminated buildings to be reoccupied in hours. In October 2001, the Hart Senate Office Building and two postal facilities were closed for over a year and remediation costs ran into the hundreds of millions of dollars after anthrax contamination.
“Preparedness is a key element of the nation’s defense against a bioterrorist attack,” Brian Larson, the president of sBioMed, said. “Terrorists are unlikely to use a biological agent if they know it won’t shut down a government building or place of business for months at a time.”
STERIPLEX Ultra uses lightweight, CO2/nitrogen-driven calibrated spray technology that covers one-square-foot in three seconds and can be used on a daily basis to clean ambulances, hospital rooms and other surfaces that harbor pathogens. STERIPLEX Ultra is one of the two sporicides registered by the EPA as an anthrax countermeasure.
“The reality is that few departments are aware the EPA has now made bleach and foams unlawful to use, creating unintentional liabilities for first responders and departments,” Dan Galloway, the CEO of 1 Priority Biocidal, the manufacturer of the BioSpray Delivery Systems, said. “They are surprised to learn that they have the ability to become compliant at a low cost, with or without grants.”
The Department of Homeland Security has made grants available to enable local governments to purchase solutions and train first responders under the new EPA requirements. The Department of Health and Human Services announced a $352 million grant program recently to help hospitals prepare for a bioterrorist attack.